chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 mins after shot numbness on both sides of my face mainly in the jaw areas/ Within 15 minutes had bilateral cheek numbness; a fullness in throat; face felt stressed; This is a spontaneous report from a contactable other HCP. This other HCP reported for a 57-year-old male patient.   A 57-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: EL3247), via intramuscularly, administered in arm left on 19Feb2021 11:15 (age at the time of vaccination 57-year-old) as single dose for COVID-19 immunization. Medical history included hypertension (mild hypertension, very healthy and active lifestyle) from an unknown date and unknown if ongoing, food allergy (mild peanut allergy) from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing (known allergies: sulfa based antibiotics). Concomitant medications included olmesartan and lot of daily vitamins taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that five mins after the shot numbness on both sides of his face mainly in the jaw areas on 19Feb2021 11:30. It lasted for five hours face felt stressed. There were no remaining results on Saturday. It was also reported that within fifteen minutes the patient had bilateral cheek numbness and a fullness in throat on 19Feb2021 11:30. There was no rash, shortness of breath, nausea, vomiting, or throat swelling. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the event. Outcome of all the events was reported as recovered 19Feb2021 16:30.   No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a licensed practical nurse refers to a patient of unknown age who on an unknown date, was vaccinated with a dose of PROQUAD (Merck) and a dose of MMR II (doses, routes and lot numbers not reported). No known adverse effects were reported. Additional information has been requested.
Information has been received from a pharmacist concerning a patient of unknown age and gender. There were no concurrent condition, medical history and concomitant therapy reported. On an unknown date, one dose of improperly stored ZOSTAVAX (lot # L027322, Expiration Date 21-OCT-2016) (strength, dose and route not provided) was administered. The vaccine was exposed to 27 F for 1 hour and to 15 F for 1 hours and 35 minutes. No adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache, Myalgia, Fever, injection site pain, fatigue Narrative:
Severe Muscle Aches began 7-8 hours after the shot Chills began 7-8 hours after the shot Elevated Heart Rate - 100BPM Resting  - When i woke up the next morning  Symptoms started going away roughly 24 hours after injection.
Received Pfizer vaccines on  3/25/21, 4/15/21, 8/30/21 has been hospitalized since 1/27/22 s/p total laryngectomy, neck dissection for malignant laryngeal cancer. Tested positive for COVID by PCR on 3/11/22 after experiencing chills, body aches, H/A, ear pain.
1530: Approximately 10 minutes after receiving vaccine patient reported having itching to throat, and hands.  Patient stated she did have a Depo-Provera Injection after 1st vaccine approximately 3 weeks ago.  Pt did state she pre-medicated herself with Benadryl 50mg orally at approximately 1300hrs today.  Mom was present with patient while covering physicians and EMS on duty assessed patient.   VS:112/82-B/P, 123-HR, 18-RR, SaO2 98% on RA.  Allergies: Steroids, fish FMHx: Sports induced asthma and gallstones.   1550: Patient had notable facial swelling eye redness and flushing. 0.15 Epinephrine IM via home Epi-Pen self delivered by patient's mother for increase SOB, and tightness in chest.  EMS transport called to transport patient to location.   VS:118/86-B/P, 100-HR, 18-RR, Sa02 96% on RA.   1600:Transfer of care to EMS staff assisting in transfer of the patient.
8.20.21 Asymptomatic day of test. 8.24.2021  Dry Cough, Muscle Aches, Fatigue, Runny nose
Headache; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and INJECTION SITE PAIN (Pain at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEADACHE (Headache) and INJECTION SITE PAIN (Pain at the injection site). At the time of the report, HEADACHE (Headache) and INJECTION SITE PAIN (Pain at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
This spontaneous report was received from a registered nurse and refers to an 10-week-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 26-DEC-2018, the patient was vaccinated with improperly stored dose of PEDVAXHIB lot # R014261, expiration date 25-MAR-2021 or lot # R005118, expiration date 28-NOV-2020 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
pt recv vax 11OCT97 & also sustained a needle stick injury 11OCT;because of the needle stick pt was tested for HIV;results were indeterminate;pt was retested for HIV 28NOV;results were again indeterminate;11DEC SUDS test neg for HIV;
Information has been received from a medical assistant referring to a patient of unknown age and gender. On 05-FEB-2015 the patient was vaccinated with VARIVAX (Merck) which underwent a supported temperature excursion, (lot# and dose not reported), subcutaneous. No adverse effects were reported. Additional information has been requested.
chills, sweats, fever, headache, body aches and pains, fatigue, nausea
Patient falsified DOB when registering for vaccination by stating the minor was born 08/10/2009. Guardian consented to the vaccination. Verified with statistical records that the patient's actual DOB is 08/10/2010, which made the vaccine a contraindication. No known adverse reactions noted.
Patient received 1st dose Pfizer vaccine 03/18/2021 Lot ER8727. Returned to be vaccinated on 03/30/2021 and received 2nd COVID vaccine brand Moderna Lot 020B21A. The wrong brand was administered to the patient and the elapsed time between vaccinations was out of range.
Cellulitis LUE after MMR Polio administration treated with Cephalexin 250/5 2 tsp TID x 10 days.
arm was sore; This is a spontaneous report from a contactable consumer. An 88-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got his on 14Jan2021, and his arm was sore in Jan2021 but he did not have any redness, itchiness, or warmth. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
In August/September ?  I developed chest congestion with productive cough.  As I have seasonal allergies and sometimes get this kind of chest congestion with it, I ignored it. As it did not go away like it has in the  past, I went to Urgent Care Nov 14 to get a chest X-Ray (PA LAT) which came out negative. As of Dec 19, the congestion is still with me, unchanged from August. It does not involve the entire lung area, only the center of my chest. The coughs are not frequent (two or three times a day). It does not interfere with mi life and is not painful. Over the fall I tested twice for COVID using home self tests and both were negative.
24 hours after the does I broke out in hives on my torso, upper thigh and forearms. The hives subsided and then returned the following evening.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021 at 3:35 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 4:15 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 50.39 for dose administered on 28-Feb-2021 and 50.47 for dose administered on 28-Mar-2021. No concomitant medications were reported. Batch number 014M20A underwent temperature excursion on 28-Feb-2021 with temperature 27 to 28 degrees Fahrenheit from 09:00 AM to 01:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 27- Feb-2021. Batch number 019B21A underwent temperature excursion on 28-Mar-2021 with temperature 35 degrees Fahrenheit from 10:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 27-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported
The patient presented to receive a Shingrex vaccine. I thought she was here for a covid vaccine and gave her that by mistake. She had already received the Pfizer vaccine with the last dose being 1 month ago
Almost two weeks after receiving moderna booster along with flu shot I woke up itchy and broke out in hives. Later that day swelling began in my fingers, feet, and knees. Hives and swelling still persist.
Pt reported a red left shoulder that was warm to the touch. Pt also reported having shown his physician at an office visit.
I have a large , red  mark on my  left arm where I got my 2nd vaccine shot two days ago on 4/30/21. It feels like it is swollen and its warm to the touch. I dont have a fever or feel bad. I just wanted to report it ...is this normal to have this reaction?
Patient reported developing symptoms 4/3/21: nausea, heartburn, loss of taste, sore belly, and "heat" around her chest. Also developed exacerbation of asthma on the morning of 4/7/21 which is when patient called the pharmacy. As of 4/7, the nausea persisted but had improved, taste had returned with diminished appetite, acid reflux/heartburn symptoms continued, and patient had difficulty breathing (though she had forgotten her inhalers the days before).
This spontaneous case, initially received from other health professional (nurse) on 24-Oct-2018, concerns a 74-year-old, elderly female patient. On 15-Oct-2018, the patient was administered expired AFLURIA (TIV) Thiomersal [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 14449221A, and expiry date: 30-Jun-2018]. On 30-Oct-2018, the patient was revaccinated with FLUCELVAX QIVc [batch number: 252660, expiry date: 31-May-2019, dose, anatomical location and route of administration: not reported]. The patient did not experience any adverse events after vaccination. The reporter assessed this case as non-serious. Follow-up received from the other health professional on 26-Nov-2018: Added FLUCELVAX QIVc (co-suspect vaccine) in the product tab as the patient was revaccinated on 30-Oct-2018. Added new event inappropriate schedule of vaccine administered in the event tab. The reporter confirmed that patient did not experience any adverse events afterward.
something like a stroke; her hands and feet got really cold; went numb on the injection side from her neck to her hands; went numb on the injection side from her neck to her hands/the side of her face went numb/numbness on the left hand in two fingers; the inside of her mouth and tongue went numb; tingling in her hands and feet; got tired; stomach felt weird; her vision is weird/one of her eyes is dilating and constricting back and forth, hard to see, sensitive to light and pupils are still different sizes; her vision is weird/one of her eyes is dilating and constricting back and forth, hard to see, sensitive to light and pupils are still different sizes; her vision is weird/one of her eyes is dilating and constricting back and forth, hard to see, sensitive to light and pupils are still different sizes; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 37-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via unspecified route on 23Mar2021 as single dose for covid-19 immunisation. Medical history included reaction to pertussis as a baby. The patient's concomitant medications were not reported. Patient stated that she reported the side effects that patient had from the first dose of the Pfizer covid 19 vaccine yesterday on 23Mar2021. patient stated that not all of the symptoms have worn off and wanted to know if she should worry, see a neurologist or is it something like a stroke on an unspecified date in Mar2021. patient stated right after the vaccine her hands and feet got really cold, went numb on the injection side from her neck to her hands and the side of her face went numb on Mar2021. Patient reported that the inside of her mouth and tongue went numb. Patient stated she had tingling in her hands and feet, got tired, stomach felt weird and today her vision is weird and one of her eyes is dilating and constricting back and forth, hard to see, sensitive to light and pupils are still different sizes on Mar2021, and patient still has a little tingling in her hands and feet and still has numbness on the left hand in two fingers but most has gone away. patient wanted to know if these are reported side effects. The outcome of the events was unknown.  Information on the lot number and batch number has been requested.
Moderna COVID-19 Vaccine EUA:  vaccine received  The arm in which I received the vaccine REALLY hurt the night I got the shot, the next day and today.
Around 10:00pm Sunday, January 16th, 2022 I noticed breakthrough bleeding from my vagina when I wiped myself after using the bathroom. It was still present this morning so I wore a panty liner and my panty liner has light blood on it today as I am typing this. I am on oral birth control and in the middle of a pack so there is no reason for this to happen now.
Report A0370297A describes sensitivity to heat in a male vaccinee of unspecified age who received Hep B vaccine recombinant (Engerix-B) for "work-related possible exposure." This report was received from the vaccinee and has not been verified by a physician or other healthcare professional. The vaccinee reportedly had no relevant medical history and received no concurrent medications. Reportedly, he had not experienced any adverse events following previous vaccinations. According to the vaccinee, in June and July 2001 he received his first & 2nd injections of Engerix-B, respectively. It was reported that beginning in approximately August 01, he began to experience sensitivity to heat and sun. Reportedly, his skin broke out in a rash, "small bumps appear that are very itchy." The vaccinee stated that he can now tolerate the cold better than the heat. The Engerix-B vaccination series was reportedly discontinued. Reportedly, no medical attention was required. As of 7/1/02, the outcomes of the events were reportedly ongoing.
Progressively worsening pain in my shoulder and neck leading to an emergency room visit on 3/18 because pain was unbearable.
event -extensive swelling limited to face - down to neck, mouth and tongue numbness, warm and tingly, increased bp  treatment - Benadryl once daily, steroids twice daily for 1 week outcome - 100% improvement (took 3-4 days)
12/19/2020-12/20/2020 only experiences soreness of left arm where vaccine received. Woke up early morning 12/21/2020 with moderate swelling of eyelids, face, lips that progressed over several hours before seeking  care at Hospital ED. Received IV Benadryl and IV solumedrol. Prescribed oral prednisone dose pack to start next day. Symptoms mostly resolved by that evening.
This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 80-year-old female patient who received SHINGRIX for prophylaxis. On 4th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 5th December 2018, 1 days after receiving SHINGRIX, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was not recovered/not resolved. It was unknown if the reporter considered the swelling arm to be related to SHINGRIX. Additional details were provided as follows: The husband reported that his wife received SHINGRIX on left arm at 4:00 PM and her arm was swollen on the date of reporting. The reporter gave consent to follow up.
Patient felt nauseated and his head began to hurt on the top. He blacked out and for a few minutes he couldn't get up. He could hear people around him talking and was taken to the school nurse's office in a wheelchair. The next day he was told that right before he blacked out he was screaming that his head hurt and he was pulling at his hair. He does not remember any of it. The day of the incident, I picked him up from school and all day he told me that the top of his head hurt.
High fever (102.9); chills, shivering, body aches, joint pain, headache, rash and swelling on left arm, tender swollen lymph nodes under left arm.
Discomfort at inj site. Redness and swelling. No streaking. No fever.
Received booster around 12 p.m. on 1 Nov 2021. That evening  felt tired and went to bed around 8 p.m.  Awoke around 2 a.m. with nerve and muscle pain in the back of my neck radiating into my shoulders and nerve and muscle pain in my lower back radiating into my lower back, hips and legs to my knees. I also had chills and a cramping pain in the middle of my chest.  Subsequently took my blood pressure and according to my monitor I had an irregular heartbeat and my blood pressure was 142/93.  My normal pressure is around 105/70. I took two aspirin and the cramping eased and my blood pressure went back down with no irregular heartbeat.   The nerve and muscle pain lasted most of the night and into the day (2 Nov 21).  About 1:30 in the afternoon the cramping in my chest returned with an elevation in blood pressure and an irregular heartbeat.  I took 1 aspirin and called my PCP who recommended that I go to a local ER and get checked out.  ECG was abnormal, troponin was 0, blood pressure had normalized.  The nerve and muscle pain has continued, with occasional muscle spasms, to the present (16 Nov 2021) with sleeplessness and anxiety over what might be causing it.  Also had a virtual visit with my PCP on November Nov 9, 2021.
Symptoms included redness and swelling at site of administration. Sharp pain radiated from site to elbow. General chills followed.  It was warm on contact.  Currently redness is decreased and site is getting better.
This spontaneous report was received from a registered nurse and refers to a 13 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 20-JUL-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N000683 with expiry date: 06-JAN-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
I started vomiting of and on around 8am 12/2/2021, so much it made my throat sore, and was unable to stop until about 2 pm the same day. Then the vomiting subsided, and I had four bowel movements which were diarrhea. I'm not stating it has anything to do with getting the Moderna booster. I'm reporting what my result was.
Approximately twelve hours post vaccine, I developed chills and nausea. I had two episodes of vomiting, the chills lasted about 90-minutes to two hours. I was able to have a fairly decent night's sleep, although quite exhausted. I ate a very bland diet on Friday, the day of the vaccine, due to a previous adverse effect after my April 2022 #4 Pfizer COVID vaccine.
10NOV92 1AM t103.5 R taken to ER; temp @ ER 104.7 R given APAP supp & pediaprophen;  pt grouchy & listless;
I had a slight runny nose for the first 2 days on the 19th and 20th. I developed a sore throat and a dry mouth. I tested negative twice. I tested positive on the 22nd of December.  By that time I had head and chest congestion and a cough. I talk to the doctor who prescribed Paxlovid. Today I woke up feeling better. I still have a cough and head congestion but I am feeling better.
Total loss of muscle response. Fell on floor and couldn't get up or move. Husband couldn't help.